A 1 ASP 0 -6.198 -5.485
A 2 SER 0 -8.116 -7.182
A 3 HIS 9 -10.309 -10.159
A 4 THR 1 -10.558 -9.459
A 5 GLN 2 -11.181 -10.125
A 6 PHE 13 -13.207 -13.183
A 7 CYS 18 -15.862 -16.108
A 8 PHE 11 -14.901 -14.453
A 9 HIS 13 -15.249 -14.990
A 10 GLY 23 -16.061 -16.859
A 11 THR 3 -15.213 -13.809
A 12 CYS 11 -14.439 -14.044
A 13 ARG 9 -12.984 -12.526
A 14 PHE 3 -11.243 -10.295
A 15 LEU 9 -10.804 -10.597
A 16 VAL 0 -8.508 -7.529
A 17 GLN 0 -7.680 -6.797
A 18 GLU 8 -8.408 -8.361
A 19 ASP 0 -7.954 -7.039
A 20 LYS 7 -9.475 -9.190
A 21 PRO 12 -11.891 -11.903
A 22 ALA 10 -14.460 -13.947
A 23 CYS 21 -16.898 -17.369
A 24 VAL 5 -16.509 -15.185
A 25 CYS 13 -16.821 -16.382
A 26 HIS 10 -14.846 -14.289
A 27 SER 0 -13.643 -12.074
A 28 GLY 1 -13.441 -12.010
A 29 TYR 16 -15.228 -15.317
A 30 VAL 5 -15.611 -14.391
A 31 GLY 14 -15.274 -15.127
A 32 ALA 2 -15.170 -13.655
A 33 ARG 8 -15.774 -14.880
A 34 CYS 20 -16.719 -17.096
A 35 GLU 6 -14.398 -13.432
A 36 HIS 6 -13.854 -12.951
A 37 ALA 1 -12.998 -11.618
A 38 ASP 13 -12.651 -12.691
A 39 LEU 2 -10.392 -9.427
A 40 LEU 4 -8.861 -8.302

Identified 0 B-Cell epitope residues out of 40 total residues